ECB zeroes in on struggling borrowers and forex as times get tougher

FRANKFURT (Reuters) – The European Central Bank on Wednesday told banks to step up how they manage struggling borrowers and their own currency trading in an environment of higher interest rates and jittery financial markets. Andrea Enria, head of the ECB’s Supervisory Board, has long worried about the economic fallout of rising borrowing costs and…

Read More
Broadcom Offered Interoperability Remedies To Address EU Antitrust Concerns Over VMware Deal -sources

Broadcom Offered Interoperability Remedies To Address EU Antitrust Concerns Over VMware Deal -sources

BRUSSELS (Reuters) – Broadcom has has offered interoperability remedies in an attempt to address EU antitrust concerns about its $61 billion bid for VMware, people familiar with the matter said. Broadcom submitted its proposal on Tuesday, a European Commission filing showed on Wednesday. The EU competition enforcer, which did not provide details in line with…

Read More

Exclusive-Polish fiscal policy should help tackle inflation – IMF

By Gergely Szakacs BUDAPEST (Reuters) – Poland’s government must ensure its fiscal policies support the fight to bring inflation down, the International Monetary Fund’s regional head told Reuters, days after fresh pre-election pledges of welfare hikes by Poland’s ruling nationalists. Law and Justice (PiS) party leader Jaroslaw Kaczynski announced on Sunday that an existing so-called…

Read More

Trump is attacking DeSantis hard on policy, amid the flurry of insults

By Tim Reid and Nathan Layne (Reuters) – Amid the headline-grabbing insults and name-calling, Donald Trump is pursuing a surprisingly policy-heavy strategy to damage his closest Republican rival Ron DeSantis before he enters the presidential race, according to a Reuters analysis of the former president’s statements since he announced his White House bid.     Forty…

Read More

Analysis-Amgen’s antitrust woes spur wider pharmaceutical deal fears

By David Carnevali NEW YORK (Reuters) – Investors are scrambling to assess the fallout of a U.S. regulatory challenge against Amgen Inc’s proposed $27.8 billion acquisition of Horizon Therapeutics Plc, with some fearing a spillover to other big deals in the drug sector. While investors are accustomed to regulators under U.S. President Joe Biden citing…

Read More

Nomura, Barclays cut China 2023 GDP forecasts as recovery sputters

BEIJING (Reuters) – Nomura has cut its forecast for China’s 2023 gross domestic product (GDP) growth to 5.5% from 5.9% previously, after April data showed a post-COVID recovery in the world’s second-largest economy is losing steam. Data on Tuesday showed China’s April factory output and retail sales growth undershot forecasts, adding pressure on policymakers to…

Read More